1,491
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1132-1135 | Received 29 May 2020, Accepted 25 Jul 2020, Published online: 03 Sep 2020

References

  • Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83‐103. PMID: 24488779. doi:10.3322/caac.21219.
  • Seth R, Singh A. Leukemias in children. Indian J Pediatr. 2015;82(9):817‐824. PMID: 25680753. doi:10.1007/s12098-015-1695-5.
  • Nilsson A, De Milito A, Engström P, Nordin M, Narita M, Grillner L, Chiodi F, Bjork O. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002;109(6):e91. PMID: 12042585. doi:10.1542/peds.109.6.e91.
  • Kızılocak H, Okcu F. Late effects of therapy in childhood acute lymphoblastic leukemia survivors. Turk J Haematol. 2019;36(1):1–11. PMID: 30398158. doi:10.4274/tjh.galenos.2018.2018.0150.
  • van Tilburg CM, Sanders EA, Rovers MM, Wolfs TF, Bierings MB. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006;20(10):1717–22. PMID: 16888619. doi:10.1038/sj.leu.2404326.
  • Fayea NY, Fouda AE, Kandil SM. Immunization status in childhood cancer survivors: A hidden risk which could be prevented. Pediatr Neonatol. 2017;58(6):541–45. PMID: 27543381. doi:10.1016/j.pedneo.2016.04.003.
  • Cesaro S, Giacchino M, Fioredda F, Barone A, Battisti L, Bezzio S, Frenos S, De Santis R, Livadiotti S, Marinello S. Guidelines on vaccinations in paediatric haematology and oncology patients. Biomed Res Int. 2014;2014:707691. PMID: 24868544. doi:10.1155/2014/707691.
  • Rubin LG, Levin MJ, Ljungman P, Davies, EG, Avery, R, Tomblyn, M, Kang, I. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host . Clin Infect Dis. 2014;58(3):e44–e100. PMID: 24311479. doi:10.1093/cid/cit816.
  • Principles of multimodal therapy. In: Pizzo PA, Poplack DG, editors Principles and practice of pediatric oncology. Philadelphia (Pa, USA): Lippincott; 2011, p. 586‐ 696.
  • Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer. 1992;69(6):1481‐1486. PMID: 1540885. doi:10.1002/1097-0142(19920315)69:6<1481::AID-CNCR2820690628>3.0.CO;2-L.
  • Crawford NW, Heath JA, Ashley D, Downie P, Buttery JP. Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr Blood Cancer. 2010;54(1):128‐133. PMID: 19785022. doi:10.1002/pbc.22256.
  • Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D’Elia R, Zanesco L, Cesaro S. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101(3):635‐641. PMID: 15717298. doi:10.1002/cncr.20384.
  • Garonzi C, Balter R, Tridello G, Pegoraro A, Pegoraro M, Pacenti M, Scattolo N, Cesaro S. The impact of chemotherapy after pediatric malignancy on humoral immunity to vaccine-preventable diseases. Mediterr J Hematol Infect Dis. 2020;12(1):e2020014. PMID: 32180909. doi:10.4084/MJHID.2020.014.
  • Fouda AE, Kandil SM, Boujettif F, Salama YS, Fayea NY. Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination. Hematology. 2018;23(9):590‐595. PMID: 29614919. doi:10.1080/10245332.2018.1460035.
  • Keskin Yildirim Z, Buyukavci M. assessment of humoral immunity to hepatitis B, measles, rubella, and mumps in children after chemotherapy. J Pediatr Hematol Oncol. 2018;40(2):e99–e102. PMID: 29309372. doi:10.1097/MPH.0000000000001072.
  • Aytac S, Yalcin SS, Cetin M, Yetgin S, Gumruk F, Tuncer M, Yurdakok K, Gurgey A. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2010;27(5):333–43. PMID: 20469978. doi:10.3109/08880011003767720.
  • Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer. 2005;44(5):461‐468. PMID: 1555877. doi:10.1002/pbc.20255.
  • Santoro N, Colombini A, Silvestri D, Grassi M, Giordano P, Parasole R, Barisone E, Caruso R, Conter V, Valsecchi MG. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience. J Pediatr Hematol Oncol. 2013;35(5):348–55. PMID: 23619106. doi:10.1097/MPH.0b013e31828dc614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.